TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Movement Quality and Experience
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Task completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of portal changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: peak work rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-point improvement in PAC-QOL scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Image readability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time from dinoprostone placement until delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of deliveries within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postcesarean endometritis
Endpoint domain: Adverse events/effects
Primary endpoint: SRI4 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of experiencing a severe flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in steroid use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in arterial SaO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in autonomic cardiac modulation (lnTP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in DFA-α1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of atelectasis
Endpoint domain: Adverse events/effects
Primary endpoint: Absorbed dose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image quality maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival at 6 years
Endpoint domain: Mortality/survival
Primary endpoint: Event-free survival at 6 years
Endpoint domain: Mortality/survival
Primary endpoint: Feasibility of the new method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation coefficient for the new method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of infants fed on demand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of cytokines and soluble form of the receptor for advanced glycation end‐products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hyperemic peak CFV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvement in clinical parameters after periodontal therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of CHD patients correctly identified on practice morbidity registers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of catheter site infections
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve (AUC) for PTSD classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall correct classification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nadir of serum ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body weight between the 25th and 50th percentiles of intrauterine growth expectations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decreased interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent-reported internalizing problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: child-reported externalizing problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: unimanual capacity of the impaired upper limb (MUUL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bimanual performance (AHA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived occupational performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Axillary sweat production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Threat-bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PO2 during 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in PCO2 during 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Walking distance during 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dosage of gonadotrophin administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increased active joint range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: costs after 1 year
Endpoint domain: Resource use
Primary endpoint: Infants meeting no screen time recommendation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Daily screen time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Television exposure during infant meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of bioactive peptides in the jejunum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevention of clinical restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: anal sphincter tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: primary PPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Median exchange time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guide wire repositioning frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of guide wire locking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on the patient visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoring moderate or better on the investigator's global improvement scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Investigator-rated pain and tenderness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature drop during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shivering frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding at discharge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in respiratory distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative anxiety (STAI-S scores)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of minor hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Efavirenz concentration above 4,000 ng/mL
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Risk of central nervous system side effects
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Risk of hepatotoxicity
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Decrease in SM values of composites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in SR values of composites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean adjusted clinical score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of norepinephrine infusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arterial stiffness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ARA content of the erythrocyte membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHA content of the erythrocyte membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of stained interface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral infarction readmission rate
Endpoint domain: Mortality/survival
Primary endpoint: Plasma fibrinogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Higher adherence category
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: transparency of optical system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3-4 granulocytopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Risk Reduction Score (RRS)
Endpoint domain: Mortality/survival
Primary endpoint: Clinical worsening-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Metabolic and inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Grade I or II nausea/vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: GSH content in peripheral mononuclear cells (PMN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor GSH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insomnia ratings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Bioequivalence of Salmeterol/Fluticasone Easyhaler
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increases in the number of prescriptions for controller medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Filing an up-to-date asthma care plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Promoting Lifestyle Profile II scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of vitamin B12 in aqueous humour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of claims for asthma due to latex exposure
Endpoint domain: Adverse events/effects
Primary endpoint: static lung compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: duration of parenteral nutrition
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: fatality rate of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Internal participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: External participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in the number of PVCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in unstable ventricular tachycardia paroxysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in red blood cells ω‐3 index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: cumulative incidence of abnormal renal findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of invasive ovarian cancer
Endpoint domain: Mortality/survival
Primary endpoint: Need for endometrial biopsies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: overall success rate of the operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Foot ulcer relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of any mental health disorder (MHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incision-making time
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Incision-closure time
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Ciliary body thickness recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean deviation from midline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of appropriate punctures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive ratios of autoantibodies against cardiac adrenergic receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average titers of autoantibodies against cardiac adrenergic receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gastrointestinal side-effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ACTH and cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction of Schirmer I test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amelioration of keratinization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in unilateral neglect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cystatin C increase ≥ 10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean percentage predicted TL(CO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean percent predicted V(C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: D(M)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Physician visit rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fitness deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: brain volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rearfoot complex dorsiflexion displacement during midstance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence of olmesartan and hydrochlorothiazide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: halothane requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OPS-pain score 30 min after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to awakening after anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recidivism
Endpoint domain: Mortality/survival
Primary endpoint: Demand for rescue medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIN remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of patients who stopped smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee functioning improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Testosterone to estradiol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 1-year stroke-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Extubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Weaning time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: wrinkle severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: wrinkle width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frequency of received paramedical care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incidence of clinically significant gastrointestinal bleed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Effectiveness of SD plasma treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of mild bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Belief in efficacy of acupuncture
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative effectiveness assessed by Macnab criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative low-density lipoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HIV infection prevalence
Endpoint domain: Mortality/survival
Primary endpoint: Conclusive HIV status rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifetime cumulative prevalence of back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 1-year prevalence of any back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Back-related disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain relief after topical administration of ibuprofen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional health literacy score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: caudate volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: total cerebral volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: putamen volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: improvements in distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perceived improvement in nursing errors
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: acyl ghrelin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction of food consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in brachial-ankle PWV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of aortic-valve replacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: overall severity of photodamage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Intra-hospital mortality for major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Control of INR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Appropriate treatment administration
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: total treatment cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intention-to-treat eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal squat and bench press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local Failure (LF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional Failure/Distal Failure (RF/DF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of quitline as a primary source of referral
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Personal motivation related to tobacco cessation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fibrinogen antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase in productive workplace hours
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvement in household productivity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: unplanned intensive care unit days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: delays in care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: interstage growth failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete regimen changes due to virological failure
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants classified as having high cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incident hypertension
Endpoint domain: Mortality/survival